Monday, April 20, 2026Global tech, startups & capital — covered for Africans.
Sproxil offers product authentication services to combat counterfeit medications.
Auto-discovered — editorial review pending
Sproxil is one of seven health-tech startups selected by the Innovations for Impact (i3) initiative to receive $225,000 in funding. The company operates across 19 countries and provides solutions for product authentication. The i3 program is coordinated by Salient Advisory and the Solina Centre for International Development and Research (SCIDaR) with support from partner organizations. In addition to funding, Sproxil will receive market-entry support and visibility through i3’s Access to Markets event.
| Date | Round | Amount | Lead |
|---|---|---|---|
| May 3, 2025 | $225K | — |
